AI ‐Enabled Automated Schistocyte Classification in Peripheral Blood for TMA Auxiliary Diagnosis
International Journal of Laboratory Hematology · 2026-12 · 48 (6) · 1486-1493
DOI: 10.1111/ijlh.70209 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, online erschienen am 05.08.2026. Verfasst von Lei Shang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Aerospace Center Hospital, Beijing, China. Hauptthemen laut MEDLINE: Thrombotic Microangiopathies, Artificial Intelligence, Erythrocytes, Abnormal. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Peking University, Aerospace Center Hospital.
Abstract (Originalsprache)
Background
Schistocytes are critical morphological markers for thrombotic microangiopathy (TMA) diagnosis. Manual identification is hampered by inconsistent standards and high interobserver variability, compromising accuracy. Although AI has advanced in hematology, AI‐enabled schistocyte classification remains under‐studied, creating a clinical gap.
Methods
We constructed a two‐stage AI system for segmentation and classification. Three segmentation models (U‐Net, ENet, and R2U‐Net) were assessed on 25 067 RBCs from 183 patients. ResNet‐50 and Xception were trained on 28 586 RBCs, including 13 125 ICSH‐classified schistocytes, using grayscale and RGB images. Clinical validation was performed on 156 784 RBCs from 219 patients. Performance was evaluated using recall, specificity, precision, and F 1 score.
Results
R2U‐Net achieved the best segmentation (recall = 0.868, F 1 = 0.881, mIoU = 0.807). The Xception‐RGB model performed best in classification (weighted F 1 = 0.957), with high precision and recall for schistocyte subtypes. Clinical validation showed excellent reliability with all weighted metrics at 0.998.
Conclusions
This two‐stage framework enables accurate schistocyte analysis with better feature representation using RGB images and Xception. It improves diagnostic accuracy and reproducibility, supporting TMA auxiliary diagnosis and clinical decision‐making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Aerospace Center Hospital, Beijing, China.
- Faculty of Engineering and Design, University of Auckland, Auckland, New Zealand.
- School of Science, Beijing Jiaotong University, Beijing, China.
- School of Public Health, Xiamen University, Xiamen, China.
ORCID-Profile: Lei Shang
Förderung
- Peking University
- Aerospace Center Hospital
Zitieren
APA
Shang, L., Fang, C., Li, D., Wang, X., Yu, J., Cui, Y., Chen, J., & Liu, X. (2026). AI ‐Enabled Automated Schistocyte Classification in Peripheral Blood for TMA Auxiliary Diagnosis. International Journal of Laboratory Hematology, 48(6), 1486-1493. https://doi.org/10.1111/ijlh.70209
Vancouver
Shang L, Fang C, Li D, Wang X, Yu J, Cui Y, et al. AI ‐Enabled Automated Schistocyte Classification in Peripheral Blood for TMA Auxiliary Diagnosis. International Journal of Laboratory Hematology. 2026;48(6):1486-1493. doi:10.1111/ijlh.70209
BibTeX
@article{Shang2026,
author = {Shang, Lei and Fang, Chao and Li, Dongshuo and Wang, Xuesong and Yu, Jiani and Cui, Yunchu and Chen, Jingliang and Liu, Xuekai},
title = {AI ‐Enabled Automated Schistocyte Classification in Peripheral Blood for TMA Auxiliary Diagnosis},
journal = {International Journal of Laboratory Hematology},
year = {2026},
volume = {48},
number = {6},
pages = {1486--1493},
doi = {10.1111/ijlh.70209}
}
EUVIMED